ÆüËÜÇÀ·Ý²½³Ø²ñ 2026ǯÅÙÂç²ñ¥×¥í¥°¥é¥à¸¡º÷

¥×¥í¥°¥é¥à½¸PDF Âç²ñ¥È¥Ã¥×¥Ú¡¼¥¸¤ËÌá¤ë
»²²Ã¾Úȯ¹Ô »²²Ã¾Úȯ¹Ô
»²²Ã¾Ú¤Ï¡¢»²²Ã¼Ô¤´¼«¿È¤ÇA4ÍÑ»æ¤Ë¥«¥é¡¼°õºþ¤Î¾å¡¢²ñ¾ì¤Ø¤´»ý»²¤¯¤À¤µ¤¤¡£ »²²Ã¾Ú¤Ï¡¢»²²Ã¼Ô¤´¼«¿È¤ÇA4ÍÑ»æ¤Ë¥«¥é¡¼°õºþ¤Î¾å¡¢²ñ¾ì¤Ø¤´»ý»²¤¯¤À¤µ¤¤¡£
Âç²ñ¥×¥í¥°¥é¥à½¸¡¦Âç²ñ¹Ö±éÍ׻ݽ¸¡ÎPDF¡Ï¤ÎÊѹ¹
¿ä¾©¥Ö¥é¥¦¥¶¡§Chrome¡¢FireFox¡¢Edge¡¢Safari
Recommended browsers: Chrome, FireFox, Edge, Safari
2A3pm05
°ìÈֱ̹é
A3
2¡ì-¥Õ¥³¥·¥ë¥é¥¯¥È¡¼¥¹¤Î¥Þ¥¦¥¹¤Ø¤Î·Ð¸ýÅêÍ¿¤ÏIJ´É·ÁÀ®¤È»é¼Á¤ÎµÛ¼ý¤òÂ¥¿Ê¤¹¤ë¡£
Oral administration of 2¡ì-Fucosyllactose promotes intestinal remodeling and enhances lipid absorption in mice.
¡ûÀ¾Àî æÆ»³ÅÄ ½¨½ÓçÕùõ Í¥ÅÍÃÏ²È ¼ãºÚÂÀϺ´Ý ¿¿Í£Èøùõ Τ¼ÂÅÄÃæ ÎÊ»ÎÀ¾ËÒ º»À㺴ƣ ÈþÍ¥¸åÆ£ ²ÖÈþ²ÃÆ£ ²íÌé±üß· ¾»²ÅµÜºä ¤é¤¤¤àîÅè Í£·î
¡ûSho NISHIKAWA Yamada Hidetoshi Yuto Funasaki Wakana Jike Mayumi Taromaru Satomi Ozaki Ryoto Tanaka Nishimaki Sayuki Miyuu Sato Hanami Goto Masaya Kato Masahiro Okuzawa Raimu Miyasaka Yuzuki Tarushima
Äëµþ²Ê³ØÂç³Ø
Teikyou Univ. Sci.
2-Fucosyllactose / DHA / absorption
Í×»Ý (PDF)
¢¨ Í×¥í¥°¥¤¥ó

Í×»ÝËÜʸ¤Ï¥È¥Ã¥×¥Ú¡¼¥¸¤«¤é¥í¥°¥¤¥ó¤ò¤·¤ÆÄº¤¯¤Èɽ¼¨¤µ¤ì¤Þ¤¹¡£